Nimoli Pharmaceuticals (P) Ltd., a active private limited company, was established on 04 August 1998 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24232DL1998PTC361925. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹4.00 M and a paid-up capital of ₹2.60 M.
Formerly known as Nimoli Pharmaceuticals Private Limited. It upholds a compliant status. Employing 22 professional, Its leadership includes Vimla Sharma (Director), Vinod Kumar Sharma (Director), Sudesh Bansal (Director). Past directors included Kulbhushan Bansal. It holds no open charges and ₹1.11 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Unit 301, Blk. Pkt. E Lsc Vikas Puri, Near Dusshera Ground, New Delhi, Delhi, 110018.
U24232DL1998PTC361925
361925
04 August 1998
₹4.00 M
₹2.60 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Nimoli Pharmaceuticals (P) Ltd. — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vimla Sharma | Director | 16 Aug 2005 | Current |
| Vinod Kumar Sharma | Director | 04 Aug 1998 | Current |
| Sudesh Bansal | Director | 16 Aug 2005 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 04 Oct 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nimoli Pharmaceuticals (P) Ltd., for the financial year ended 2022, experienced significant growth in revenue, with a 12.34% increase. The company also saw a substantial improvement in profitability, with a 25.38% increase in profit. The company's net worth moved up by a moderate rise of 7.44%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Nimoli Pharmaceuticals (P) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹11,050,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Jun 2017 | Axis Bank Limited | ₹7.50 M | Satisfied |
| 13 Jan 2011 | Icici Bank Limited | ₹3.55 M | Satisfied |
Explore comprehensive loan charge details -
Nimoli Pharmaceuticals (P) has a workforce of 22 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Nimoli Pharmaceuticals (P), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nimoli Pharmaceuticals (P)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Nimoli Pharmaceuticals (P) Ltd. last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
A charge registered on 19 Jun 2017 via Charge ID 100109326 with Axis Bank Limited was fully satisfied on 13 Aug 2024. was recorded as a recent event.
Nimoli Pharmaceuticals (P) Ltd. has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
The activity A charge with Axis Bank Limited of Rs. 7.50 M registered on 19 Jun 2017 with Charge ID 100109326 was modified on 03 Aug 2018. was completed.
A charge with Axis Bank Limited amounted to Rs. 7.50 M with Charge ID 100109326 was registered on 19 Jun 2017. was recorded as a recent event.
The activity A charge registered on 13 Jan 2011 via Charge ID 10266541 with Icici Bank Limited was fully satisfied on 29 May 2017. was completed.
The CIN of Nimoli Pharmaceuticals (P) Ltd. is U24232DL1998PTC361925.
Nimoli Pharmaceuticals (P) Ltd. is headquartered at Unit 301, Blk. Pkt. E Lsc Vikas Puri, Near Dusshera Ground, New Delhi, Delhi, 110018.
Nimoli Pharmaceuticals (P) Ltd. was incorporated on 04 August 1998.
The current directors of Nimoli Pharmaceuticals (P) Ltd. are
The primary industry of Nimoli Pharmaceuticals (P) Ltd. is Manufacturing.
Nimoli Pharmaceuticals (P) Ltd. is unlisted.
The authorized capital of Nimoli Pharmaceuticals (P) Ltd. is ₹4.00 M, and the paid-up capital is ₹2.60 M.
The compliance status of Nimoli Pharmaceuticals (P) Ltd. is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX